The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Patagonia Lithium Ltd (ASX:PL3) has widened its footprint in Argentina, gaining an additional 15 exploration concessions – which it believes are highly prospective for rare earth elements and lithium – bringing the company’s total granted concessions in the country to 18.

The 15 new applications are for exploration within the Minas Gerais state, and will run for three years.

Within this territory, Patagonia has identified three key areas with high priority targets for REEs in ionic clays, or lithium pegmatites.

Executive chairman Phillip Thomas said Patagonia’s exploration team was already active on the ground, rolling out rockchip, soil and stream sampling to test the prospectivity of the land.

“We now have a major component of our exploration concessions granted and the team is already in trucks mapping and sampling along the priority targets from the substantial geophysics we have conducted,” he said.

“This campaign is earmarked to be conducted quickly so we can shore up our drill targets
and additionally high intensity sampling.”

Patagonia Lithium has been trading at 10 cents.

PL3 by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024

The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
The Market Online Video

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…